Daphne Vassiliou
Stockholm, AB 14186, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Treatment goals for adults with early treated PKU should be determined by evidence-based shared decision making between patients and their medical team.
Journal: Orphanet journal of rare diseases
Published: November 28, 2025
Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patients.
Journal: Journal of inherited metabolic disease
Published: May 25, 2023
Maternal and fetal outcomes in acute hepatic porphyria: A Swedish National Cohort Study.
Journal: Journal of inherited metabolic disease
Published: January 18, 2023
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals.
Journal: Journal of inherited metabolic disease
Published: October 12, 2022
Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947.
Journal: Cancers
Published: August 23, 2022
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
Journal: Journal of internal medicine
Published: February 03, 2022
Acute hepatic porphyria and maternal health: Clinical and biochemical follow-up of 44 pregnancies.
Journal: Journal of internal medicine
Published: August 19, 2021
A Drug-Drug Interaction Study Evaluating the Effect of Givosiran, a Small Interfering Ribonucleic Acid, on Cytochrome P450 Activity in the Liver.
Journal: Clinical pharmacology and therapeutics
Published: July 19, 2021
Homocysteine elevation in givosiran treatment: Suggested ALAS1 siRNA effect on cystathionine beta-synthase.
Journal: Journal of internal medicine
Published: June 29, 2021
Treatment with assisted reproduction technologies in women with acute hepatic porphyria.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: March 04, 2021
Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients.
Journal: Genome medicine
Published: June 29, 2020
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
Journal: The New England journal of medicine
Published: June 11, 2020
Last Updated: 09/26/2026